Global Point of Care Hematology Diagnostics Market Size, Share, and COVID-19 Impact Analysis, By Type (Completed Blood Count (CBC), Coagulation Testing, Hemoglobin Testing and Anemia Diagnosis, and Others), By Mode of Prescription (Prescription based product and OTC based product), By End User (Diagnostic Centers, Hospitals, Blood Banks & Transfusion Centers, and Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 - 2035

Global Point of Care Hematology Diagnostics Market Insights Forecasts to 2035

• The Global Point of Care Hematology Diagnostics Market Size Was Estimated at USD 2.5 Billion in 2024
• The Market Size is Expected to Grow at a CAGR of around 5.70% from 2025 to 2035
• The Worldwide Point of Care Hematology Diagnostics Market Size is Expected to Reach USD 4.6 Billion by 2035
• Asia Pacific is expected to Grow the Fastest during the Forecast Period.

The Global Point of Care Hematology Diagnostics Market Size was Worth around USD 2.5 Billion in 2024 and is Predicted to Grow to around USD 4.6 Billion by 2035 with a compound annual growth rate (CAGR) of 5.70% from 2025 to 2035. An increasing need for rapid & accurate blood testing in the emergency & remote settings, as well as the growing prevalence of blood-related disorders, are driving the point of care hematology diagnostics market globally.

Market Overview

The point of care hematology diagnostics market refers to the industry for hematological tests, which analyse blood components, at or near the patient’s location, rather than in a central laboratory. Point of care hematology diagnostics is a clinical laboratory test conducted close to the site of patient care where treatment is provided. It has improved clinical or economic outcomes compared to laboratory testing. The market development includes the miniaturization of electronics with improved instrumentation, which is revolutionizing POCT, enabling the development of smaller and more accurate devices. Integration of digital technologies, including AI and cloud-based data management, in the diagnostics landscape for improving the accuracy and speed of hematological testing and enabling better data tracking & remote monitoring is escalating market growth opportunities.

Report Coverage

This research report categorizes the point of care hematology diagnostics market based on various segments and regions, forecasts revenue growth, and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the point of care hematology diagnostics market. Recent market developments and competitive strategies such as expansion, type launch, development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the point of care hematology diagnostics market.

Driving Factors

An increasing demand for immediate clinical decisions, along with upsurging demand for rapid and accurate blood testing at the patient’s bedside, is contributing to driving the market demand for point of care hematology diagnostics. Further, an increasing need for effective disease management, including frequent blood monitoring and early detection, owing to the rising prevalence of blood-related disorders, including anemia, leukemia, and haemophilia contributing to propel the market growth.

Restraining Factors

An increased cost of devices, as well as concerns associated with the accuracy & reliability of PoC testing, are restricting the point of care hematology diagnostics market. The shortage of skilled workforce, especially in the underdeveloped regions, limits its adoption, thereby hampering the market growth.

Market Segmentation

The point of care hematology diagnostics market share is classified into type, mode of prescription, and end user.

• The completed blood count (CBC) segment dominated the market with the largest share in 2024 and is projected to grow at a substantial CAGR during the forecast period.

Based on the type, the point of care hematology diagnostics market is divided into completed blood count (CBC), coagulation testing, hemoglobin testing and anemia diagnosis, and others. Among these, the completed blood count (CBC) segment dominated the market with the largest share in 2024 and is projected to grow at a substantial CAGR during the forecast period. CBC is a common blood test used for detecting a wide range of disorders, such as anemia, infection and leukemia, autoimmune disorders, bone marrow disorders, and lymphoma. The widespread application of completed blood count hematology diagnostics across primary care, emergency settings, and pre-surgical evaluations is driving the market growth.

• The prescription based product segment accounted for the dominant market share in 2024 and is anticipated to grow at a significant CAGR during the forecast period.

Based on the mode of prescription, the point of care hematology diagnostics market is divided into prescription based product and OTC based product. Among these, the prescription based product segment accounted for the dominant market share in 2024 and is anticipated to grow at a significant CAGR during the forecast period. There is an increased prioritization towards prescription-based point-of-care hematology devices owing to their increased reliability, regulatory approval, and established treatment protocols. The growing presence of pipeline candidates for various therapeutic applications is contributing to the market growth.

• The hospitals segment accounted for the largest market share in 2024 and is anticipated to grow at a significant CAGR during the forecast period.

Based on the end user, the point of care hematology diagnostics market is divided into diagnostic centers, hospitals, blood banks & transfusion centers, and others. Among these, the hospitals segment accounted for the largest market share in 2024 and is anticipated to grow at a significant CAGR during the forecast period. Point of care hematology diagnostics enable faster decision-making, especially in emergencies, and can improve patient outcomes and potentially reduce hospital stays. Further, the availability of advanced diagnostic infrastructure, with an increasing demand for rapid diagnostics in non-traditional care settings, aids in propelling the market growth.

Regional Segment Analysis of the Point of Care Hematology Diagnostics Market

• North America (U.S., Canada, Mexico) 
• Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
• Asia-Pacific (China, Japan, India, Rest of APAC)
• South America (Brazil and the Rest of South America) 
• The Middle East and Africa (UAE, South Africa, Rest of MEA)

North America is anticipated to hold the largest share of the point of care hematology diagnostics market over the predicted timeframe.

North America is anticipated to hold the largest share of the point of care hematology diagnostics market over the predicted timeframe. An increasing demand for POC diagnostic tests, owing to their ability to deliver immediate results, is driving the market demand. The presence of well-established healthcare infrastructure, along with an emphasis on early disease detection & preventive care, is contributing to propel the market.

Asia Pacific is expected to grow at a rapid CAGR in the point of care hematology diagnostics market during the forecast period.  The prevalence of hematological and chronic diseases in densely populated countries like China and India is responsible for driving the point of care hematology diagnostics market demand. Further, awareness about early disease detection as well as demand for rapid & accurate diagnostic results aids in promoting the market growth.

Europe is anticipated to hold a significant share of the point of care hematology diagnostics market during the predicted timeframe. The presence of a well-established healthcare framework, along with the growing prevalence of blood-related disorders, is escalating the market for point of care hematology diagnostics. Further, the market is driven by the adoption of technical advancements for enhancing the quality of point of care diagnostics, as well as an increasing number of in-house hospital laboratories opting for PoC diagnostics.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the point of care hematology diagnostics market, along with a comparative evaluation primarily based on their type of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes type development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Abbott
• Madison Medical Diagnostics LLC
• Sysmex Corporation
• EKF Diagnostics
• Danaher Corporation
• Siemens Healthineers
• PixCell Medical Technologies Ltd
• F.Hoffman-La Roche Ltd
• Thermo Fisher Scientific
• Bio-Rad Laboratories
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting And Research Firm
• Venture capitalists
• Value-Added Resellers (VARs) 

Recent Development

• In February 2024, CellaVision and Sysmex signed a strategic alliance agreement to reinforce and extend their joint leadership position within hematology and seize new opportunities for optimized diagnostics.
• In January 2024, HORIBA Medical launched the new HELO 2.0 high-throughput automated hematology platform, which is CE-IVDR approved, with pending US FDA approval.

Market Segment

This study forecasts revenue at global, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the point of care hematology diagnostics market based on the below-mentioned segments: 

Global Point of Care Hematology Diagnostics Market, By Type

• Completed Blood Count (CBC)
• Coagulation Testing
• Hemoglobin Testing and Anemia Diagnosis
• Others

Global Point of Care Hematology Diagnostics Market, By Mode of Prescription

• Prescription based product
• OTC based product

Global Point of Care Hematology Diagnostics Market, By End User

• Diagnostic Centers
• Hospitals
• Blood Banks & Transfusion Centers
• Others

Global Point of Care Hematology Diagnostics Market, By Regional Analysis

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of the Middle East & Africa